PROF250117P15000
- 0.00
- 0.000.00%
Profound Medical Newsroom
Does Profound Medical (PROF) Have the Potential to Rally 100.13% as Wall Street Analysts Expect?
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Profound Medical (PRN) Receives a Buy From Lake Street
Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break
Profound Medical Successfully Prices Public Offering to Boost Commercialization Efforts
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock
Express News | Profound Medical Corp : Raymond James Cuts Target Price to $17 From $19
Raymond James Initiates Profound Medical(PROF.US) With Buy Rating, Announces Target Price $17
Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)
Profound Stock Slides 6% on $35M Public Offering Pricing
Trading Halt: Halted at 9:10:08 A.m. ET - Trading Halt: Halt News Pending
Profound Medical Down 6.7% In US After Hours As Announces Proposed Public Offering of Common Shares
Profound Medical Brief: Announcing Proposed Public Offering of Common Shares
Profound Medical, Siemens Healthineers Enter Co-sales, Co-marketing Agreement
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Profound Medical Brief: Says It and Siemens Healthineers to Offer a "Complete Solution" for MRI-guided Prostate Therapy
Profound Medical Advancements in Prostate Treatment
Profound Medical Brief: Says to Unveil Next TULSA-AI Module, 'UA Alignment Assistant'
Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant'
Profound Medical to Present at Stifel Conference